Tamoxifen Citrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 11 USDMF, 6 CEP/COS, 3 JDMF, 4 KDMF, 14 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

8 Intermediates Suppliers

8 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

127 FDF Dossiers, 26 FDA Orange Book, 54 Europe, 6 Canada, 14 Australia, 9 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - EQ 20MG BASE/10ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 4 DKSH, 7 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 24 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 40 Direct Compression, 28 Controlled & Modified Release, 26 Thickeners and Stabilizers, 26 Granulation, 23 Disintegrants & Superdisintegrants, 21 Taste Masking, 21 Co-Processed Excipients, 20 Film Formers & Plasticizers, 17 Solubilizers, 16 Chewable & Orodispersible Aids, 16 Parenteral, 14 Lubricants & Glidants, 13 Topical, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Emulsifying Agents, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 53 Finished Drug Prices

MARKET PLACE

6 APIs, 9 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 17970 / DOSAGE - TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Tamoxifen citrate(UNII: 7FRV7310N6) (Tamoxifen - UNII:094ZI81Y45)	Tamoxifen	20mg \| 10mg

Inactive Ingredients

Ingredient Name	AstraZeneca Pharmaceuticals LP
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311)
magnesium stearate(70097M6I30)
mannitol(3OWL53L36A)
STARCH, POTATO(8I089SAH3T)

Drug Product Composition: Tamoxifen Citrate